12:00 AM
 | 
Dec 03, 2012
 |  BC Week In Review  |  Company News  |  Deals

Alacris Theranostics, GlaxoSmithKline deal

The companies partnered to apply Alacris' ModCell system to early stage cancer drug development. GlaxoSmithKline will provide Alacris preclinical data from a cancer compound. Alacris will...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >